Effectiveness of Telerehabilitation for Work-Related Musculoskeletal Disorders in Cardiac Sonographers

September 4, 2025 updated by: Shibili Nuhmani, Imam Abdulrahman Bin Faisal University

Effectiveness of Telerehabilitation in the Management of Work-Related Musculoskeletal Disorders in Cardiac Sonographers

Work-related musculoskeletal disorders(WRMDs) are common among cardiac sonographers due to their nature of work. This study aims to find out the effectiveness of the telerehabilitation method in the management of WRMDs among cardiac sonographers. 38 cardiac sonographers diagnosed with WRMDs will be randomly allocated into experimental and control groups with an allocation ratio1:1. The Experimental group will be receiving the telerehabilitation program along with an ergonomic awareness education program for 6 weeks, and the control group will receive an ergonomic awareness education alone. Pain, quality of life and work satisfaction are the outcome measures which will be measured at the baseline and after 6 weeks of the program

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
    • Eastern Province
      • Dammam, Eastern Province, Saudi Arabia, 34521
        • Imamabdulrahman bin fasial univeristy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Cardiac sonographers with work-related musculoskeletal pain.
  • Cardiac sonographers practicing adult echocardiography predominantly working in public hospitals, private hospitals or/and private outpatient clinics in Saudi Arabia.

Exclusion Criteria:

  • Systematic diseases as reported by the participants such as Diabetes Miletus and Fibromyalgia.
  • Using cardiac medications or the pain killer as reported by the participants.
  • Any biomechanical abnormalities based on the evaluation of a qualified physical therapist.
  • Any other musculoskeletal disorders or injuries which is not related to WRMDs.
  • Any recent surgery which may affect the ability to participate in the exercise program.
  • Any other contraindications to participate in the exercise program.
  • Pregnancy in female participants.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patient education
Other: Patient education
Patient education will be given to both the experimental and control groups. Patient education and telerehabilitation will be given to the experimental group. To the control group, patient education alone will be provided
Experimental: Tele rehabilitation
Other: Telerehabilitation
The experimental group will be given a tailored program of telerehabilitation consisting of stretching and strengthening exercises for six weeks (three times per week)
Other: Patient education
Patient education will be given to both the experimental and control groups. Patient education and telerehabilitation will be given to the experimental group. To the control group, patient education alone will be provided

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work satisfaction
Time Frame: baseline and immediately after 6 weeks of the program
Work satisfaction measured by The job satisfaction scale
baseline and immediately after 6 weeks of the program
Pain measured by Numeric Pain Rating Scale
Time Frame: baseline and immediately after 6 weeks of the program
Numeric Pain Rating Scale is a 11-point scale where the minimum score is 0 (indicating no pain) and the maximum score is 10 (representing the worst possible pain)
baseline and immediately after 6 weeks of the program
Quality of life measured by Short Form (36) Health Survey questionnaire
Time Frame: baseline and immediately after 6 weeks of the program
  • The Short Form (36) Health Survey questionnaire contains 36 items that cover eight distinct health domains:
  • Physical Functioning
  • Role Limitations due to Physical Health
  • Role Limitations due to Emotional Problems
  • Energy/Fatigue (Vitality)
  • Emotional Wellbeing (Mental Health)
  • Social Functioning
  • Pain (Bodily Pain)
  • General Health Perceptions
  • Each domain is scored on a scale from 0 to 100.
  • Higher scores indicate better perceived health and quality of life.
baseline and immediately after 6 weeks of the program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Imam Abdulrahman Bin Faisal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2025

Primary Completion (Actual)

May 20, 2025

Study Completion (Actual)

June 10, 2025

Study Registration Dates

First Submitted

February 18, 2025

First Submitted That Met QC Criteria

February 18, 2025

First Posted (Actual)

February 24, 2025

Study Record Updates

Last Update Posted (Estimated)

September 11, 2025

Last Update Submitted That Met QC Criteria

September 4, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB-2025-03-0129

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Work Related Musculoskeletal Disorders

Clinical Trials on Telerehabilitation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe